These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 3363536
1. Preoperative identification of patients at high risk of deep venous thrombosis despite prophylaxis in total hip replacement. Rocha E, Alfaro MJ, Páramo JA, Cañadell JM. Thromb Haemost; 1988 Feb 25; 59(1):93-5. PubMed ID: 3363536 [Abstract] [Full Text] [Related]
2. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis. Páramo JA, Alfaro MJ, Rocha E. Thromb Haemost; 1985 Oct 30; 54(3):713-6. PubMed ID: 3937269 [Abstract] [Full Text] [Related]
3. Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine. Alfaro MJ, Páramo JA, Rocha E. Thromb Haemost; 1986 Aug 20; 56(1):53-6. PubMed ID: 3535158 [Abstract] [Full Text] [Related]
4. Evaluation of preoperative blood tests for predicting deep vein thrombosis after total hip replacement. Mindner K, Bergmann I, Sturm G, Liedloff H, Hindersin P, Gleiser W, Till U, Vogel G. Haematologia (Budap); 1988 Aug 20; 21(1):47-55. PubMed ID: 3396975 [Abstract] [Full Text] [Related]
5. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination. Perhoniemi V, Vuorinen J, Myllynen P, Kivioja A, Lindevall K. Ann Chir Gynaecol; 1996 Aug 20; 85(4):359-63. PubMed ID: 9014067 [Abstract] [Full Text] [Related]
6. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine. Haas S, Stemberger A, Fritsche HM, Welzel D, Wolf H, Lechner F, Blümel G. Arzneimittelforschung; 1987 Jul 20; 37(7):839-43. PubMed ID: 2823840 [Abstract] [Full Text] [Related]
7. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion. Trotti R, Siragusa S, Rondanelli M, Chezzi L, Citterio A, Melzi d'Eril GV, Piovella F. Haematologica; 1997 Jul 20; 82(2):178-81. PubMed ID: 9175322 [Abstract] [Full Text] [Related]
8. [Thromboembolic disease and changes in coagulation after total hip arthroplasty. Effect of prophylaxis with acetylsalicylic acid or heparin-dihydroergotamine]. Alfaro M, Páramo JA, de Pablos J, Cañadell J, Rocha E. Sangre (Barc); 1986 Jul 20; 31(2):145-55. PubMed ID: 3726711 [No Abstract] [Full Text] [Related]
9. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients. Urlep-Salinović V, Jelatancev B, Gorisek B. Thromb Haemost; 1994 Jul 20; 72(1):16-20. PubMed ID: 7974365 [Abstract] [Full Text] [Related]
10. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action. Comerota AJ, Stewart GJ, White JV. Am J Surg; 1985 Oct 08; 150(4A):39-44. PubMed ID: 3901791 [Abstract] [Full Text] [Related]
18. Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement. Hoek JA, Nurmohamed MT, ten Cate JW, Büller HR, Knipscheer HC, Hamelynck KJ, Marti RK, Sturk A. Thromb Haemost; 1989 Dec 29; 62(4):1050-2. PubMed ID: 2559485 [Abstract] [Full Text] [Related]